Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Motoaki Tanigawa is active.

Publication


Featured researches published by Motoaki Tanigawa.


American Journal of Hematology | 1997

Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.

Yuko Kamikura; Hideo Wada; Atsushi Yamada; Minori Shimura; Katsuyo Hiyoyama; Hiroshi Shiku; Motoaki Tanigawa; Hideo Nishikawa; Norikazu Yamada; Naoki Isaka; Takeshi Nakano; Kousuke Kumeda; Hisao Kato

We examined hemostatic abnormalities in 23 patients with acute myocardial infarction (AMI), 10 with pulmonary embolism (PE), and 10 with deep vein thrombosis (DVT). At the onset of AMI, plasma levels of tissue‐type plasminogen activator (t‐PA), PA inhibitor‐I (PAI‐I), fibrin‐D‐dimer, thrombin‐antithrombin complex (TAT), and plasmin‐plasmin inhibitor complex (PPIC) were significantly increased. Both the plasma total TFPI and free‐TFPI levels in the AMI patients were significantly higher than those in the healthy volunteers, PE patients, and DVT patients. There was no significant difference in total TFPI or free‐TFPI among patients with PE, those with DVT, and healthy volunteers. One hour after percutaneous transluminal coronary angioplasty (PTCA) in the AMI group, the total TFPI level was further increased, and it was significantly reduced 24 hr after PTCA, to a level similar to that in healthy volunteers. Free‐TFPI showed a pattern similar to that of total TFPI. The ratio of free‐TFPI/total TFPI was highest 1 hr after PTCA. Increased TFPI in AMI patients might be released from ischemic tissues. Am. J. Hematol. 55:183–187, 1997.


Internal Medicine | 2019

Ovarian Metastases from ALK-rearranged Lung Adenocarcinoma: A Case Report and Literature Review

Hajime Sasano; Akimasa Sekine; Toru Hirata; Keisuke Iwamoto; Yuhei Itou; Hidetoshi Itani; Shigeto Kondou; Toshiya Tokui; Motoaki Tanigawa

We herein report a 37-year-old woman with lung adenocarcinoma with brain metastases and an asymptomatic ovarian tumor. Immunohistochemistry and a fluorescent in situ hybridization analysis of the biopsied lung tumor revealed anaplastic lymphoma kinase (ALK) gene rearrangement. Although the origin of the ovarian tumor remained unclear, alectinib administration was initiated, and radiological responses were observed in all lesions, which confirmed that the ovarian tumor was a metastasis from lung cancer. Although differentiating the origin of an ovarian tumor is difficult in lung cancer patients due to the rarity of ovarian metastases, alectinib therapy can replace an invasive biopsy, especially in ALK-rearranged lung cancer patients.


Respiratory medicine case reports | 2018

Lung abscess caused by Streptococcus pneumoniae serotype 6B

Yuhei Ito; Hirokazu Toyoshima; Takehiro Suzuki; Keisuke Iwamoto; Hajime Sasano; Hidetoshi Itani; Shigeto Kondo; Motoaki Tanigawa

Lung abscess has been considered to be a rare complication of pneumococcal infection, and most cases are reported to be Streptococcus pneumoniae serotype 3. A 67-year-old man presented with fever and was diagnosed to have lung abscess caused by S. pneumoniae serotype 6B. The minimal inhibitory concentration (MIC) of penicillin for the isolate was 1 μg/mL. He was treated with high-dose intravenous sulbactam/ampicillin as definitive therapy based on susceptibility testing for S. pneumoniae and recovered successfully without surgical intervention. S. pneumoniae serotype 6B can cause lung abscess.


American Journal of Hematology | 2000

HTLV‐1 unrelated adult T‐cell leukemia/lymphoma with unique phenotype and karyotype

Kazunori Nakase; Masaki Hasegawa; Kota Tsuji; Takeshi Ikeda; Shigehisa Tamaki; Motoaki Tanigawa; Eiki Miyanishi; Hiroshi Shiku

We describe a unique case of adult T‐cell leukemia/lymphoma (ATL). The patient had typical clinicohematological features as ATL, but showed a lack of antibody to human T‐cell leukemia virus type‐1 (HTLV‐1) and was negative for HTLV‐I proviral DNA in the peripheral mononuclear cells by means of polymerase chain reaction. The phenotype of tumor cells revealed CD7+, CD5+, CD2+, CD3+, WT31−, TcR δ 1−, CD4−, CD8−, CD25−, and the karyotype showed a 5q‐, t(12;18). HTLV‐I unrelated ATL is very rare, and the karyotype as in our case has not been reported previously. Am. J. Hematol. 64:64–66, 2000.


Journal of the Japan Society of the Reticuloendothelial System | 1992

Generation of Tissue Factor Activity by Mononuclear Cells, Vascular Endothelial Cells and Vascular Endothelial Cells incubated with Mononuclear Cells Supernatants.

Motoaki Tanigawa; Hideo Wada; Mitiaki Ohiwa; Toshihiro Kaneko; Sigehisa Tamaki; Mikio Takagi; Shigeru Shirakawa

We examined the tissue factor (TF) activity in human mononuclear cells (MNCs), human umbilical vein endothelial cells (HUVECs) or HUVECs incubated with the medium from MNCs. The TF activity of HUVEC cultured without stimulation was hardly detected, but that of MNC cultured without it increased until 18 hours. When they were cultured with lipopolysaccharide (LPS) and cytokines, the TF activity was further increased dose-dependently, and reached a maximum within 6-12 hours. The TF activity of MNC cultured with LPS, interleukin-1 (IL-1) and interleukin-6 (IL-6) was significantly increased. That of HUVEC cultured with LPS, IL-1 or tumor necrosis factor (TNF) was markedly increased. Furthermore, TF activity of HUVEC incubated with the medium from MNCs cultured with various cytokines was more increased. Although TF activity of HUVEC or MNC cultured with colony stimulating factor and interferron was hardly increased, that of HUVEC incubated with the medium from MNC cultured with them was markedly increased. The TF activity of HUVEC incubated with the medium from MNCs cultured with LPS was dependent on the cell number of cultured MNC. LPS-stimulated MNC also released TNF and IL-1, and the levels within 12-24 hours. We speculated that MNCs and vascular endothelial cells interacted together and played an important role in hemostasis.


American Journal of Hematology | 1992

Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation

Hideo Wada; Michiaki Ohiwa; Toshihiro Kaneko; Shigehisa Tamaki; Motoaki Tanigawa; Shigeru Shirakawa; Masato Koyama; Tatsuya Hayashi; Koji Suzuki


American Journal of Hematology | 1993

Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia

Hideo Wada; Yoshitaka Mori; Toshihiro Kaneko; Yoshihiro Wakita; Tutomu Nakase; Kouzou Minamikawa; Michiaki Ohiwa; Shigehisa Tamaki; Motoaki Tanigawa; Sinichi Kageyama; Katsumi Deguchi; Takeshi Nakano; Shigeru Shirakawa; Koji Suzuki


American Journal of Hematology | 1993

Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura

Hideo Wada; Toshihiro Kaneko; Michiaki Ohiwa; Motoaki Tanigawa; Tatsuya Hayashi; Shigehisa Tamaki; Nobuyuki Minami; Katsumi Deguchi; Koji Suzuki; Takeshi Nakano; Shigeru Shirakawa


Thrombosis and Haemostasis | 1994

INCREASED ACTIVATED PROTEIN C-PROTEIN C INHIBITOR COMPLEX LEVELS IN PATIENTS WITH PULMONARY EMBOLISM

Kouzou Minamikawa; Hideo Wada; Yoshihiro Wakita; Michiaki Ohiwa; Motoaki Tanigawa; Katsumi Deguchi; Hiraoka N; Huzioka H; Nishioka J; Tatsuya Hayashi


American Journal of Hematology | 1992

Plasma cytokine levels in thrombotic thrombocytopenic purpura.

Hideo Wada; Toshihiro Kaneko; Michiaki Ohiwa; Motoaki Tanigawa; Shigehisa Tamaki; Nobuyuki Minami; Hoyu Takahashi; Katsumi Deguchi; Takeshi Nakano; Shigeru Shirakawa

Collaboration


Dive into the Motoaki Tanigawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge